0001493152-21-020734.txt : 20210819
0001493152-21-020734.hdr.sgml : 20210819
20210819191001
ACCESSION NUMBER: 0001493152-21-020734
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210817
FILED AS OF DATE: 20210819
DATE AS OF CHANGE: 20210819
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Opaleye Management Inc.
CENTRAL INDEX KEY: 0001595855
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35814
FILM NUMBER: 211191360
BUSINESS ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: SUITE 2600
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-904-9195
MAIL ADDRESS:
STREET 1: ONE BOSTON PLACE
STREET 2: SUITE 2600
CITY: BOSTON
STATE: MA
ZIP: 02108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HARROW HEALTH, INC.
CENTRAL INDEX KEY: 0001360214
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450567010
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
BUSINESS PHONE: 615.733.4731
MAIL ADDRESS:
STREET 1: 102 WOODMONT BLVD
STREET 2: SUITE 610
CITY: NASHVILLE
STATE: TN
ZIP: 37215
FORMER COMPANY:
FORMER CONFORMED NAME: Imprimis Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20120301
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20070912
FORMER COMPANY:
FORMER CONFORMED NAME: Bywater Resources, Inc
DATE OF NAME CHANGE: 20060421
4
1
ownership.xml
X0306
4
2021-08-17
0
0001360214
HARROW HEALTH, INC.
HROW
0001595855
Opaleye Management Inc.
ONE BOSTON PLACE, 26TH FLOOR
BOSTON
MA
02108
0
0
1
0
Common Stock, par value $0.0001 per share
2021-08-17
4
P
0
25000
8.5661
A
3040000
I
By Opaleye, L.P.
Common Stock, par value $0.0001 per share
2021-08-17
4
P
0
1000
8.5661
A
146000
I
By Managed Account
Common Stock, par value $0.0001 per share
2021-08-18
4
P
0
45000
8.6447
A
3085000
I
By Opaleye, L.P.
Common Stock, par value $0.0001 per share
2021-08-18
4
P
0
1500
8.6447
A
147500
I
By Managed Account
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $8.5661. The range of purchase prices on the transaction date was $8.39 to $8.75 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye may be deemed to beneficially own the securities owned directly by the Managed Account.
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $ 8.6447. The range of purchase prices on the transaction date was $8.59 to $8.69 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Opaleye Management Inc., By: /s/ James Silverman, President
2021-08-19